Archemix

Archemix is a drug discovery and development company founded by experts in molecular biology and drug discovery, and backed by experienced biotech investors. Using proprietary technologies, we create biotherapeutics and drug discovery tools. Working independently and through alliances with pharmaceutical partners, we are committed to driving the science of making better medicines.

Contact Details: 1 Hampshire Street Cambridge MA United States of America Tel: (617) 621 700 Fax: (617) 225 6965 Email: info@archemix.com. WWW: www.archemix.com/

Recent Publications by Archemix:
Predictive toxicogenomics in preclinical discovery. The failure of drug candidates during clinical trials due to toxicity,...	6th August, 2008	Toxicology, Archemix Corp., Cambridge, Massachusetts, USA.	Methods Mol Biol. 2008;460:89-112. DOI Direct Link
SELEX with modified nucleotides. Aptamers, a promising new class of therapeutics, are single-stranded...	23rd July, 2008	Archemix Corp., 300 Third Street, Cambridge, MA 02142, USA.	Curr Opin Chem Biol. 2008 Jul 21. DOI Direct Link
Aptamers as candidate therapeutics for cardiovascular indications. The first therapeutic aptamer was approved for human use in 2004, and a...	23rd July, 2008	Archemix Corporation, 300 Third Street, Cambridge, MA 02142, USA.	Curr Opin Pharmacol. 2008 Apr;8(2):147-52. Epub 2008 Jan 28. DOI Direct Link
Complex target SELEX. Aptamers are non-naturally occurring structured oligonucleotides that may...	29th May, 2008	Archemix Corporation, 300 Third Street, Cambridge, Massachusetts 02142,	Acc Chem Res. 2008 Jan;41(1):130-8. DOI Direct Link
First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. BACKGROUND: ARC1779 is a therapeutic aptamer antagonist of the A1 domain...	8th February, 2008	Archemix Corp., 300 Third St, Cambridge, MA 02142, USA.	Circulation. 2007 Dec 4;116(23):2678-86. Epub 2007 Nov 19. DOI Direct Link
→View more Archemix research publications.

BioNews Results for Archemix:
BioSpectrum Top 20: Japan's emerging sectors	Bio Spectrum Asia:  Aug 26 2008 11:29AM Matching: archemix
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172	KOTA Territory News:  Aug 15 2008 8:29AM Matching: archemix
Archemix grants rights to develop aptamers to Ribomic for multiple targets	PharmaBiz:  Aug 14 2008 12:00PM Matching: archemix
Archemix signs Ribomic to aptamer deal; $6M up front	Checkbiotech:  Aug 14 2008 1:07PM Matching: archemix
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172	KLFY:  Aug 14 2008 5:34PM Matching: archemix
Promote your company here: BioNewsCast - Press Release Distribution	→View more Archemix news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 237 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: Archemix | Archemix Corp | Archemix Corp | Archemix Corp AND UK | archemix.com | archemix.com | archemix | archemix | archemix.com | archemix | .

Search for more companies in Cambridge

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Archemix